Figure 7

The gene mutational landscape. (A–B) Waterfall plot of the top 20 mutant genes in the low-, and high-risk group. (C) The Kaplan–Meier analysis curves for GC patients with low or high tumor mutation burden. (D) The Kaplan–Meier analysis curves for the GC patients stratified by NKCAS and TMB.